In addition, Zappasodi et al. observed that blocking the transformation of pyruvate into lactate in combination with an anti-CTLA4 antibody decreased glucose uptake of tumor cells, whereas Treg cells increased glucose consumption, altering their suppressive capacity [100]. The gene discussed is CTLA4; the disease is neoplasm.